Skip to main content

Advertisement

Table 3 Prevalence of the comorbidities investigated (n = 125)

From: Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: a case–control study

Comorbidity Age < 50 years, n = 65 Age ≥ 50 years, n = 60 Odds ratio (95% CI) P value
Systemic arterial hypertension 2 (3.1%) 20 (33%) 15.1 (3.3–68.1) < 0.001
Osteoarthritis 3 (4.6%) 20 (33.3%) 9.9 (2.7–35.5) < 0.001
Hyperlipidemia 40 (61.5%) 49 (81.7%) 2.9 (1.2–6.6) 0.009
Diabetes mellitus 1 (1.5%) 11 (18.3%) 13.8 (1.7–110.9) 0.002
Acid peptic disease 4 (6.2%) 12 (20%) 3.6 (1.15–12.1) 0.032
Obesity, BMI > 30 kg/m2 3 (4.6%) 11 (18.3%) 4.47 (1.18–16.9) 0.023
HBV coinfection 6 (9.2%) 11 (18.3%) 2.12 (0.73–6.16) 0.158
Heart failure and/or coronary heart disease 1 (1.5%) 1 (1.7%) 1.05 (0.64–17.16) 1.0
Chronic kidney disease 3 (4.6%) 4 (6.7%) 1.42 (0.30–6.65) 0.713
Current malignant tumors 2 (2.7%) 4 (6.7%) 2.25 (0.39–12.75) 0.348
Current sexually transmitted disease 21 (32.3%) 11 (18.3%) 0.47 (0.20–1.08) 0.074
Liver disease 0 (0%) 2 (3.3%)   0.138
Chronic obstructive pulmonary disease 0 (0%) 1 (1.7%)   0.296
  1. Data are presented as the number (%)